Medical News

RSS

First Edition: May 12, 2011

Today's headlines include reports about the upcoming speech by GOP presidential hopeful Mitt Romney, during which he is expected to confront what many say is his main vulnerability: his home state's health reform.

12 May 2011

ChromaDex first quarter 2011 revenue increases 31% to $2,539,245

ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced financial results for the first quarter of 2011.

12 May 2011

With today's speech, Romney hopes to inoculate himself on health care issues

Mitt Romney, the former governor of Massachusetts and a likely GOP presidential hopeful, will deliver a speech today in which he will confront his biggest political vulnerability — the fact that the state health reform he signed into law as governor is often considered a prototype for the federal health law.

12 May 2011

Insurer rates spark attention

In Connecticut, Aetna is proposing rate cuts for this year, a move that reflects, at least partially, the impact of the federal health law. Meanwhile, The Hill reports that consumer groups are anxiously awaiting regulations that will allow the Department of Health and Human Services to review rates. These regs are likely to be out by the end of the month.

12 May 2011

McGill research team finds distinct disease-causing mutations and saves baby girl

About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).

12 May 2011

59-year-old enrolls in study of stem cell transplantation during cardiac bypass

A 59-year-old Houston man became the first individual in the United States to enroll in a study using stem cell transplantation during cardiac bypass to treat severe heart failure.

12 May 2011

$100,000 needed to analyze '$1,000' genetic data

Advances in technology have almost lifted the curtain on the long-awaited era of the "$1,000 genome" - a time when all the genes that make up a person can be deciphered for about that amount - compared to nearly $1 million a few years ago.

12 May 2011

Researchers help explain why smart drugs are not effective in some cancer patients

Some of the most effective and expensive cancer drugs, dubbed "smart drugs" for their ability to stop tumors by targeting key drivers of cancer cell growth, are not effective in some patients. In two related studies, Yale School of Medicine researchers examined one such driver, the EGF receptor, and found that a decoy receptor might be limiting the amount of drug that gets to the intended target.

12 May 2011

ETI finalizes proprietary progesterone formulations for Traumatic Brain Injury

Encore Therapeutics, Inc. today reported finalizing its proprietary phospholipid nanoemulsion formulation of progesterone.

12 May 2011

Chemical engineer builds working models of human tissues for disease research

Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, is building working models of human bone, breast, liver and artery tissues to see how cells behave when they are affected by a disease such as cancer.

12 May 2011

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in patients having a stroke.

12 May 2011

InTouch Health applauds FDA for recent announcement on Medical Device Data Systems

In response to the recent announcement issued by the Food and Drug Administration regarding Medical Device Data Systems, InTouch Health affirms its position of compliance, and applauds the agency for issuing regulations governing the use of hardware and software in the healthcare information technology space.

12 May 2011

Medtronic to present new clinical results on innovative medical devices at EuroPCR

New clinical data on a range of innovative medical devices from Medtronic, Inc., to treat cardiac and vascular diseases - from severe aortic stenosis and uncontrolled hypertension, to coronary and peripheral artery disease - will be presented next week at EuroPCR. Many of the presentations will be featured during late-breaking sessions at this large international interventional cardiology meeting, which takes place in Paris from May 17-20.

From Medtronic 12 May 2011

Bovie Medical first quarter revenues increase 10% to $6.2 million

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter and year ended March 31, 2011.

12 May 2011

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.

12 May 2011

Cipher first quarter net revenue decreases to $0.7 million

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three months ended March 31, 2011.

12 May 2011

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.

12 May 2011

Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies

Linguamatics, the leader in NLP-based enterprise text mining for life sciences and other markets, announces the latest release of its award-winning software platform, I2E.

12 May 2011

Aradigm first quarter total revenue decreases to $0.2 million

Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2011.

12 May 2011

New organocatalyst now available for drug development industry

A new "organocatalyst" developed at Oregon State University is now available for commercial use. Produced by an Albany, Ore., pharmaceutical company, it should make new drug development around the world less costly, more efficient and more environmentally friendly.

12 May 2011

Medical News

First Edition: May 12, 2011

ChromaDex first quarter 2011 revenue increases 31% to $2,539,245

With today's speech, Romney hopes to inoculate himself on health care issues

Insurer rates spark attention

McGill research team finds distinct disease-causing mutations and saves baby girl

59-year-old enrolls in study of stem cell transplantation during cardiac bypass

$100,000 needed to analyze '$1,000' genetic data

Researchers help explain why smart drugs are not effective in some cancer patients

ETI finalizes proprietary progesterone formulations for Traumatic Brain Injury

Chemical engineer builds working models of human tissues for disease research

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

InTouch Health applauds FDA for recent announcement on Medical Device Data Systems

Medtronic to present new clinical results on innovative medical devices at EuroPCR

Bovie Medical first quarter revenues increase 10% to $6.2 million

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Cipher first quarter net revenue decreases to $0.7 million

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies

Aradigm first quarter total revenue decreases to $0.2 million

New organocatalyst now available for drug development industry

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News